Addition of Intravesical Recombinant Bacillus Calmette-Guérin to Perioperative Chemoimmunotherapy in Muscle-Invasive Bladder Cancer: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/19

Journal:
Journal of Clinical Oncology
Published:
DOI:
10.1200/jco-26-00845
Affiliations:
20
Authors:
25
Go to article
Institutions Authors Share
Department of Biomedicine Basel, Switzerland
3.500000
 0.14
University Hospital Basel (USB), UB, Switzerland
3.500000
 0.14
University Hospital Zurich (UHZ), Switzerland
3.000000
 0.12
Kantonsspital Graubünden, Switzerland
3.000000
 0.12
Swiss Cancer Institute, Switzerland
2.000000
 0.08
Klinik Hirslanden, Switzerland
2.000000
 0.08
Kantonsspital Baden AG (KSB), Switzerland
2.000000
 0.08
Kantonsspital Lucerne, Switzerland
1.250000
 0.05
Lindenhofspital, Switzerland
1.000000
 0.04
Ente Ospedaliero Cantonale (EOC), Switzerland
1.000000
 0.04
Kantonsspital St. Gallen, Switzerland
1.000000
 0.04
Geneva University Hospitals (HUG), Switzerland
1.000000
 0.04
Cantonal Hospital of Winterthur (KSW), Switzerland
0.250000
 0.01
University of Lucerne (UNILU), Switzerland
0.250000
 0.01
University of Zurich (UZH), Switzerland
0.250000
 0.01